0001735276-20-000095.txt : 20200821 0001735276-20-000095.hdr.sgml : 20200821 20200821160657 ACCESSION NUMBER: 0001735276-20-000095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200820 FILED AS OF DATE: 20200821 DATE AS OF CHANGE: 20200821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARAGANORE JOHN CENTRAL INDEX KEY: 0001180432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 201123485 MAIL ADDRESS: STREET 1: 75 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-08-20 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001180432 MARAGANORE JOHN 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 1 1 0 0 Chief Executive Officer Common Stock 2020-08-20 4 M 0 34765 9.14 A 232354 D Common Stock 2020-08-20 4 S 0 4775 135.09 D 227579 D Common Stock 2020-08-20 4 S 0 21448 136.07 D 206131 D Common Stock 2020-08-20 4 S 0 8542 136.86 D 197589 D Common Stock 3133 I by Managed Account Stock Option (right to buy) 9.14 2020-08-20 4 M 0 34765 0.0 D 2020-12-08 Common Stock 34765 34765 D All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2019. The 34,765 options exercised and sold by the reporting person were due to expire on December 8, 2020. Sale prices ranged from $134.52 to $135.52. Sale prices ranged from $135.58 to $136.58. Sale prices ranged from $136.59 to $137.55. Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. By: /s/ Mary Beth DeLena, Attorney-in-Fact For: John M. Maraganore 2020-08-21